Benjamin P. Saylor is associate editor of Urology Times, an Advanstar Communications publication.
High cystectomy-free survival seen with nadofaragene treatment in NMIBC
December 9th 2024"Overall, the take-home message is that in patients with BCG-unresponsive non–muscle invasive bladder cancer, you can consider nadofaragene as an option among those that are available for treating these patients," said Vikram Narayan, MD.
Satisfaction compared for IPP reservoir placement in prevesical vs ectopic location
October 19th 2024“The take-home message…is it doesn't matter whether you put the reservoir in the ectopic location or the prevesical location. Patients tend to be satisfied in both locations,” said Mohit Khera, MD, MBA, MPH.